123 related articles for article (PubMed ID: 2586947)
1. Papanicolaou smear screening interval and risk of cervical cancer.
Shy K; Chu J; Mandelson M; Greer B; Figge D
Obstet Gynecol; 1989 Dec; 74(6):838-43. PubMed ID: 2586947
[TBL] [Abstract][Full Text] [Related]
2. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
3. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
4. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
5. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
6. [Possible link between long-term oral contraceptive use and cervical cancer].
Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
[TBL] [Abstract][Full Text] [Related]
7. Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols.
Bearman DM; MacMillan JP; Creasman WT
Obstet Gynecol; 1987 Feb; 69(2):151-5. PubMed ID: 3808501
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for in situ cervical cancer: results from a case-control study.
Jones CJ; Brinton LA; Hamman RF; Stolley PD; Lehman HF; Levine RS; Mallin K
Cancer Res; 1990 Jun; 50(12):3657-62. PubMed ID: 2340514
[TBL] [Abstract][Full Text] [Related]
9. Optimal frequency of screening for cervical cancer: a Toronto case-control study.
Clarke EA; Hilditch S; Anderson TW
IARC Sci Publ; 1986; (76):125-31. PubMed ID: 3570399
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of Papanicolaou screening in Sweden: record linkage between a central screening registry and the National Cancer Registry.
Pettersson F; Näslund I; Malker B
IARC Sci Publ; 1986; (76):91-105. PubMed ID: 3570419
[TBL] [Abstract][Full Text] [Related]
12. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of cervical neoplasia.
La Vecchia C
Biomed Pharmacother; 1985; 39(8):426-33. PubMed ID: 3841750
[TBL] [Abstract][Full Text] [Related]
14. Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.
Silfverdal L; Kemetli L; Andrae B; Sparén P; Ryd W; Dillner J; Strander B; Törnberg S
Am J Obstet Gynecol; 2009 Aug; 201(2):188.e1-7. PubMed ID: 19560117
[TBL] [Abstract][Full Text] [Related]
15. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
[TBL] [Abstract][Full Text] [Related]
16. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
17. Quality assessment of cervical screening: a population-based case-control study in the C te-D'Or region, France.
Chaplain G; Quantin C; Brunet-Lecomte P; Mottot C; Michiels-Marzais D; Sasco AJ
Cancer Detect Prev; 2001; 25(1):40-7. PubMed ID: 11270420
[TBL] [Abstract][Full Text] [Related]
18. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
van Aspert-van Erp AJ; Smedts FM; Vooijs GP
Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
[TBL] [Abstract][Full Text] [Related]
19. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
20. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
